BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28614959)

  • 1. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism.
    Wang X; Zhang X; Liu F; Wang M; Qin S
    Pharm Biol; 2017 Dec; 55(1):1863-1867. PubMed ID: 28614959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of puerarin on the pharmacokinetics of triptolide in rats.
    Wang Q; Wu Y; Xiang F; Feng Y; Li Z; Ding Y
    Pharm Biol; 2019 Dec; 57(1):407-411. PubMed ID: 31230510
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of triptolide on pharmacokinetics of fenofibrate in rats and its potential mechanism.
    Li T; Liu J; Zheng Y; Yang S; Liu X; Li X
    Xenobiotica; 2019 Feb; 49(2):211-215. PubMed ID: 29412757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: a possible role of cytochrome P3A4 inhibition.
    Zhang XF; Liu J; Ye F; Ji SG; Zhang N; Cao RS; He L; Wu JC; Li XF
    Chin J Integr Med; 2014 Jul; 20(7):534-9. PubMed ID: 24420925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects.
    Huang F; Ajavon A; Huang E; Lettieri J; Liu R; Peña C; Berse M
    Thyroid; 2017 Sep; 27(9):1118-1127. PubMed ID: 28741453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice.
    Edginton AN; Zimmerman EI; Vasilyeva A; Baker SD; Panetta JC
    Cancer Chemother Pharmacol; 2016 May; 77(5):1039-52. PubMed ID: 27053087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide.
    Jia Y; Liu J; Xu J
    Xenobiotica; 2018 Apr; 48(4):407-411. PubMed ID: 28359180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver.
    Murray M; Gillani TB; Ghassabian S; Edwards RJ; Rawling T
    Eur J Pharm Sci; 2018 Mar; 114():55-63. PubMed ID: 29223619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
    Zhao M; Lee SH; Song JG; Kim HY; Han HK
    Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.
    Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC
    Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitor.
    Choo EF; Woolsey S; DeMent K; Ly J; Messick K; Qin A; Takahashi R
    Drug Metab Dispos; 2015 Jun; 43(6):864-9. PubMed ID: 25813936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS.
    Zhang C; Gao Z; Niu L; Chen X
    Pharm Biol; 2018 Dec; 56(1):132-137. PubMed ID: 29385884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method.
    Gong X; Chen Y; Wu Y
    Molecules; 2015 May; 20(5):8928-40. PubMed ID: 25993421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats.
    Ting CT; Cheng YY; Tsai TH
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28640225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological evaluation of a novel sorafenib analogue, t-CUPM.
    Wecksler AT; Hwang SH; Liu JY; Wettersten HI; Morisseau C; Wu J; Weiss RH; Hammock BD
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):161-71. PubMed ID: 25413440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glycyrrhizin on the pharmacokinetics of nobiletin in rats and its potential mechanism.
    Wang H; Dong L; Qu F; He H; Sun W; Man Y; Jiang H
    Pharm Biol; 2020 Dec; 58(1):352-356. PubMed ID: 32298152
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism.
    Sun H; Wang J; Lv J
    Pharm Biol; 2019 Dec; 57(1):550-554. PubMed ID: 31429612
    [No Abstract]   [Full Text] [Related]  

  • 18. Ontogeny and sorafenib metabolism.
    Zimmerman EI; Roberts JL; Li L; Finkelstein D; Gibson A; Chaudhry AS; Schuetz EG; Rubnitz JE; Inaba H; Baker SD
    Clin Cancer Res; 2012 Oct; 18(20):5788-95. PubMed ID: 22927483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylation.
    Sugiyama M; Fujita K; Murayama N; Akiyama Y; Yamazaki H; Sasaki Y
    Drug Metab Dispos; 2011 May; 39(5):757-62. PubMed ID: 21266595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.
    Zhang H; Ya G; Rui H
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):89-98. PubMed ID: 26874845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.